COVID-19 Impact on Global Visceral Pain Treatment Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Visceral Pain Treatment Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Visceral Pain Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 HS-665
  • 1.4.3 CC-8464
  • 1.4.4 BLU-5937
  • 1.4.5 APD-371
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Visceral Pain Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 In-patient
  • 1.5.3 Out-patient
• 1.6 Coronavirus Disease 2019 (Covid-19): Visceral Pain Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Visceral Pain Treatment Industry
    • 1.6.1.1 Visceral Pain Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Visceral Pain Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Visceral Pain Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Visceral Pain Treatment Market Perspective (2015-2026)
• 2.2 Visceral Pain Treatment Growth Trends by Regions
  • 2.2.1 Visceral Pain Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Visceral Pain Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Visceral Pain Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Visceral Pain Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Visceral Pain Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Visceral Pain Treatment Players by Market Size
  • 3.1.1 Global Top Visceral Pain Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Visceral Pain Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Visceral Pain Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Visceral Pain Treatment Market Concentration Ratio
  • 3.2.1 Global Visceral Pain Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Visceral Pain Treatment Revenue in 2019
• 3.3 Visceral Pain Treatment Key Players Head office and Area Served
• 3.4 Key Players Visceral Pain Treatment Product Solution and Service
• 3.5 Date of Enter into Visceral Pain Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Visceral Pain Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Visceral Pain Treatment Forecasted Market Size by Type (2021-2026)

5 Visceral Pain Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Visceral Pain Treatment Market Size by Application (2015-2020)
• 5.2 Global Visceral Pain Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Visceral Pain Treatment Market Size (2015-2020)
• 6.2 Visceral Pain Treatment Key Players in North America (2019-2020)
• 6.3 North America Visceral Pain Treatment Market Size by Type (2015-2020)
• 6.4 North America Visceral Pain Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Visceral Pain Treatment Market Size (2015-2020)
• 7.2 Visceral Pain Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Visceral Pain Treatment Market Size by Type (2015-2020)
• 7.4 Europe Visceral Pain Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Visceral Pain Treatment Market Size (2015-2020)
• 8.2 Visceral Pain Treatment Key Players in China (2019-2020)
• 8.3 China Visceral Pain Treatment Market Size by Type (2015-2020)
• 8.4 China Visceral Pain Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Visceral Pain Treatment Market Size (2015-2020)
• 9.2 Visceral Pain Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Visceral Pain Treatment Market Size by Type (2015-2020)
• 9.4 Japan Visceral Pain Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Visceral Pain Treatment Market Size (2015-2020)
• 10.2 Visceral Pain Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Visceral Pain Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Visceral Pain Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Visceral Pain Treatment Market Size (2015-2020)
• 11.2 Visceral Pain Treatment Key Players in India (2019-2020)
• 11.3 India Visceral Pain Treatment Market Size by Type (2015-2020)
• 11.4 India Visceral Pain Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Visceral Pain Treatment Market Size (2015-2020)
• 12.2 Visceral Pain Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Visceral Pain Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Visceral Pain Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Addex Therapeutics Ltd
  • 13.1.1 Addex Therapeutics Ltd Company Details
  • 13.1.2 Addex Therapeutics Ltd Business Overview and Its Total Revenue
  • 13.1.3 Addex Therapeutics Ltd Visceral Pain Treatment Introduction
  • 13.1.4 Addex Therapeutics Ltd Revenue in Visceral Pain Treatment Business (2015-2020))
  • 13.1.5 Addex Therapeutics Ltd Recent Development
• 13.2 Astellas Pharma Inc.
  • 13.2.1 Astellas Pharma Inc. Company Details
  • 13.2.2 Astellas Pharma Inc. Business Overview and Its Total Revenue
  • 13.2.3 Astellas Pharma Inc. Visceral Pain Treatment Introduction
  • 13.2.4 Astellas Pharma Inc. Revenue in Visceral Pain Treatment Business (2015-2020)
  • 13.2.5 Astellas Pharma Inc. Recent Development
• 13.3 Chromocell Corporation
  • 13.3.1 Chromocell Corporation Company Details
  • 13.3.2 Chromocell Corporation Business Overview and Its Total Revenue
  • 13.3.3 Chromocell Corporation Visceral Pain Treatment Introduction
  • 13.3.4 Chromocell Corporation Revenue in Visceral Pain Treatment Business (2015-2020)
  • 13.3.5 Chromocell Corporation Recent Development
• 13.4 GIcare Pharma Inc
  • 13.4.1 GIcare Pharma Inc Company Details
  • 13.4.2 GIcare Pharma Inc Business Overview and Its Total Revenue
  • 13.4.3 GIcare Pharma Inc Visceral Pain Treatment Introduction
  • 13.4.4 GIcare Pharma Inc Revenue in Visceral Pain Treatment Business (2015-2020)
  • 13.4.5 GIcare Pharma Inc Recent Development
• 13.5 Grunenthal GmbH
  • 13.5.1 Grunenthal GmbH Company Details
  • 13.5.2 Grunenthal GmbH Business Overview and Its Total Revenue
  • 13.5.3 Grunenthal GmbH Visceral Pain Treatment Introduction
  • 13.5.4 Grunenthal GmbH Revenue in Visceral Pain Treatment Business (2015-2020)
  • 13.5.5 Grunenthal GmbH Recent Development
• 13.6 Medestea Research & Production S.p.A.
  • 13.6.1 Medestea Research & Production S.p.A. Company Details
  • 13.6.2 Medestea Research & Production S.p.A. Business Overview and Its Total Revenue
  • 13.6.3 Medestea Research & Production S.p.A. Visceral Pain Treatment Introduction
  • 13.6.4 Medestea Research & Production S.p.A. Revenue in Visceral Pain Treatment Business (2015-2020)
  • 13.6.5 Medestea Research & Production S.p.A. Recent Development
• 13.7 Neurim Pharmaceuticals Ltd
  • 13.7.1 Neurim Pharmaceuticals Ltd Company Details
  • 13.7.2 Neurim Pharmaceuticals Ltd Business Overview and Its Total Revenue
  • 13.7.3 Neurim Pharmaceuticals Ltd Visceral Pain Treatment Introduction
  • 13.7.4 Neurim Pharmaceuticals Ltd Revenue in Visceral Pain Treatment Business (2015-2020)
  • 13.7.5 Neurim Pharmaceuticals Ltd Recent Development
• 13.8 Pfizer Inc.
  • 13.8.1 Pfizer Inc. Company Details
  • 13.8.2 Pfizer Inc. Business Overview and Its Total Revenue
  • 13.8.3 Pfizer Inc. Visceral Pain Treatment Introduction
  • 13.8.4 Pfizer Inc. Revenue in Visceral Pain Treatment Business (2015-2020)
  • 13.8.5 Pfizer Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer